Home MOMA Therapeutics

MOMA Therapeutics

In operation
Series B
Targeted ATPase (ATPase) Developer

Basic Information

MOMA Therapeutics is committed to discovering the next generation of precision medicines by targeting molecular machines involved in human diseases. The company integrates groundbreaking scientific advances in biochemistry, biophysics, structural biology, chemistry, and functional genomics to build a platform that leverages a key vulnerability inherent to all such enzymes: their reliance on the coordinated, stepwise changes in protein conformation. By focusing this platform on disease-causing targets, MOMA aims to develop highly effective, precision medicines for patients with unmet medical needs.
MOMA Therapeutics
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2020
info@momatx.com